China-based Zai Lab Limited has announced the appointment of Josh Smiley as its Chief Operating Officer (COO). Smiley brings over 26 years of experience working within the biopharmaceutical industry, including experience leading finance, corporate strategy, business development, venture capital and the Global Business Services operations at Eli Lilly and Co (Lilly).

Smiley will report directly to Dr Samantha Du, CEO and Chair of the Board of Zai Lab, and will be a key member of Zai Lab’s executive committee. He will oversee all aspects of business, finance, and global operations. Smiley will be COO of Zai Lab beginning on August 1, 2022, following the completion of his leave with his current employer.

He began his career at Lilly in 1995, holding leadership positions across the organization culminating in his most recent role of Senior Vice President and Chief Financial Officer. Smiley will relocate to the Boston area and be based in Zai Lab’s office in Cambridge, Massachusetts, US.